Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,424
archived clinical trials in
Cognitive Studies

Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic - Las Vegas
mi
from
Las Vegas, NV
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic - Las Vegas
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated:  12/31/1969
Dent Neurological Institute
mi
from
Amherst, NY
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated: 12/31/1969
Dent Neurological Institute
mi
from
Amherst, NY
Click here to add this to my saved trials
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated:  12/31/1969
New York Univ. Medical Center
mi
from
New York, NY
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated: 12/31/1969
New York Univ. Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated:  12/31/1969
Weill-Cornell Medical College
mi
from
New York, NY
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated: 12/31/1969
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated:  12/31/1969
University of Rochester
mi
from
Rochester, NY
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated: 12/31/1969
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated:  12/31/1969
Wake Forest University School of Medicine
mi
from
Winston-Salem, NC
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated: 12/31/1969
Wake Forest University School of Medicine
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated:  12/31/1969
Case Western Reserve University
mi
from
Beachwood, OH
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated: 12/31/1969
Case Western Reserve University
mi
from
Beachwood, OH
Click here to add this to my saved trials
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated:  12/31/1969
Tulsa Clinical Research
mi
from
Tulsa, OK
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated: 12/31/1969
Tulsa Clinical Research
mi
from
Tulsa, OK
Click here to add this to my saved trials
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated:  12/31/1969
Drexel University College of Medicine at EPPI
mi
from
Philadelphia, PA
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated: 12/31/1969
Drexel University College of Medicine at EPPI
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated:  12/31/1969
University of Pennsylvania Hospital
mi
from
Philadelphia, PA
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated: 12/31/1969
University of Pennsylvania Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated:  12/31/1969
Butler Hospital
mi
from
Providence, RI
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated: 12/31/1969
Butler Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated:  12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated: 12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated:  12/31/1969
Roper Hospital
mi
from
Charleston, SC
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated: 12/31/1969
Roper Hospital
mi
from
Charleston, SC
Click here to add this to my saved trials
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated:  12/31/1969
UT Southwestern Medical Center
mi
from
Dallas, TX
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated: 12/31/1969
UT Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated:  12/31/1969
Baylor College of Medicine
mi
from
Houston, TX
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated:  12/31/1969
Houston Methodist
mi
from
Houston, TX
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated: 12/31/1969
Houston Methodist
mi
from
Houston, TX
Click here to add this to my saved trials
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated:  12/31/1969
University of Washington School of Medicine
mi
from
Seattle, WA
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated: 12/31/1969
University of Washington School of Medicine
mi
from
Seattle, WA
Click here to add this to my saved trials
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin-Madison Hospital and Health Clinic
mi
from
Madison, WI
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin-Madison Hospital and Health Clinic
mi
from
Madison, WI
Click here to add this to my saved trials
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated:  12/31/1969
Mount Sinai School of Medicine
mi
from
New York, NY
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated: 12/31/1969
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated:  12/31/1969
Research Site
mi
from
Parkville,
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated: 12/31/1969
Research Site
mi
from
Parkville,
Click here to add this to my saved trials
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated:  12/31/1969
Barrow Neurological Institute
mi
from
Phoenix, AZ
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated: 12/31/1969
Barrow Neurological Institute
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated:  12/31/1969
Sutter Medical Group
mi
from
Sacramento, CA
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated: 12/31/1969
Sutter Medical Group
mi
from
Sacramento, CA
Click here to add this to my saved trials
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated:  12/31/1969
Syrentis Clinical Research
mi
from
Santa Ana, CA
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated: 12/31/1969
Syrentis Clinical Research
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated:  12/31/1969
Brain Matters Research
mi
from
Delray Beach, FL
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated: 12/31/1969
Brain Matters Research
mi
from
Delray Beach, FL
Click here to add this to my saved trials
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated:  12/31/1969
Veterans Affairs Medical Center - Palo Alto
mi
from
Palo Alto, CA
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated: 12/31/1969
Veterans Affairs Medical Center - Palo Alto
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated:  12/31/1969
Georgetown University Hospital
mi
from
Washington,
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated: 12/31/1969
Georgetown University Hospital
mi
from
Washington,
Click here to add this to my saved trials
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated:  12/31/1969
Howard University Hospital
mi
from
Washington,
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Status: Enrolling
Updated: 12/31/1969
Howard University Hospital
mi
from
Washington,
Click here to add this to my saved trials
Phase 2 Clinical Trial of SGS-742 Therapy in Succinic Semialdehyde Dehydrogenase Deficiency
Phase 2 Clinical Trial of SGS-742 Therapy in Succinic Semialdehyde Dehydrogenase Deficiency
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Phase 2 Clinical Trial of SGS-742 Therapy in Succinic Semialdehyde Dehydrogenase Deficiency
Phase 2 Clinical Trial of SGS-742 Therapy in Succinic Semialdehyde Dehydrogenase Deficiency
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Phase 2 Clinical Trial of SGS-742 Therapy in Succinic Semialdehyde Dehydrogenase Deficiency
Phase 2 Clinical Trial of SGS-742 Therapy in Succinic Semialdehyde Dehydrogenase Deficiency
Status: Enrolling
Updated:  12/31/1969
Washington State University
mi
from
Pullman, WA
Phase 2 Clinical Trial of SGS-742 Therapy in Succinic Semialdehyde Dehydrogenase Deficiency
Phase 2 Clinical Trial of SGS-742 Therapy in Succinic Semialdehyde Dehydrogenase Deficiency
Status: Enrolling
Updated: 12/31/1969
Washington State University
mi
from
Pullman, WA
Click here to add this to my saved trials
Effects of Gilenya (Fingolimod) on Thalamus Pathology and Cognitive Impairment in Patients With Relapsing Forms of Multiple Sclerosis
Open-label, Single-blinded, Observational, Prospective, 24-months, Longitudinal, Controlled Study to Assess the Efficacy of Gilenya® on Development of Thalamus Pathology and Cognitive Impairment in Patients With Relapsing Forms of Multiple Sclerosis.
Status: Enrolling
Updated:  12/31/1969
Buffalo Neuroimaging Analysis Center
mi
from
Buffalo, NY
Effects of Gilenya (Fingolimod) on Thalamus Pathology and Cognitive Impairment in Patients With Relapsing Forms of Multiple Sclerosis
Open-label, Single-blinded, Observational, Prospective, 24-months, Longitudinal, Controlled Study to Assess the Efficacy of Gilenya® on Development of Thalamus Pathology and Cognitive Impairment in Patients With Relapsing Forms of Multiple Sclerosis.
Status: Enrolling
Updated: 12/31/1969
Buffalo Neuroimaging Analysis Center
mi
from
Buffalo, NY
Click here to add this to my saved trials
Psychotherapy for Anxiety in Children With Autism Spectrum Disorder
2/3 Treatment of Anxiety in Autism Spectrum Disorder
Status: Enrolling
Updated:  12/31/1969
Rothman Center for Neuropsychiatry, University of South Florida
mi
from
Saint Petersburg, FL
Psychotherapy for Anxiety in Children With Autism Spectrum Disorder
2/3 Treatment of Anxiety in Autism Spectrum Disorder
Status: Enrolling
Updated: 12/31/1969
Rothman Center for Neuropsychiatry, University of South Florida
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder
Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder
Status: Enrolling
Updated:  12/31/1969
New York State Psychiatric Institute
mi
from
New York, NY
Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder
Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder
Status: Enrolling
Updated: 12/31/1969
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment
A Controlled, Randomized, Two-arm, Open-label, Assessor-blinded, Multicenter Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment
Status: Enrolling
Updated:  12/31/1969
Children's Hospital and Research Center Oakland
mi
from
Oakland, CA
Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment
A Controlled, Randomized, Two-arm, Open-label, Assessor-blinded, Multicenter Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment
Status: Enrolling
Updated: 12/31/1969
Children's Hospital and Research Center Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment
A Controlled, Randomized, Two-arm, Open-label, Assessor-blinded, Multicenter Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment
Status: Enrolling
Updated:  12/31/1969
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment
A Controlled, Randomized, Two-arm, Open-label, Assessor-blinded, Multicenter Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment
Status: Enrolling
Updated: 12/31/1969
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment
A Controlled, Randomized, Two-arm, Open-label, Assessor-blinded, Multicenter Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment
Status: Enrolling
Updated:  12/31/1969
Univ of North Carolina
mi
from
Chapel Hill, NC
Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment
A Controlled, Randomized, Two-arm, Open-label, Assessor-blinded, Multicenter Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment
Status: Enrolling
Updated: 12/31/1969
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment
A Controlled, Randomized, Two-arm, Open-label, Assessor-blinded, Multicenter Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment
Status: Enrolling
Updated:  12/31/1969
Women's and Children's Hospital, 72 King William Road
mi
from
North Adelaide,
Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment
A Controlled, Randomized, Two-arm, Open-label, Assessor-blinded, Multicenter Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment
Status: Enrolling
Updated: 12/31/1969
Women's and Children's Hospital, 72 King William Road
mi
from
North Adelaide,
Click here to add this to my saved trials
Nattokinase Atherothrombotic Prevention Study
Nattokinase Atherothrombotic Prevention Study
Status: Enrolling
Updated:  12/31/1969
University of Southern California Atherosclerosis Research Unit
mi
from
Los Angeles, CA
Nattokinase Atherothrombotic Prevention Study
Nattokinase Atherothrombotic Prevention Study
Status: Enrolling
Updated: 12/31/1969
University of Southern California Atherosclerosis Research Unit
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Child and Family Outcomes and Consumer Satisfaction for Online vs Staff-Delivered Parenting Intervention
Online vs Staff Delivery: Child & Family Outcomes, Value Analysis, Satisfaction
Status: Enrolling
Updated:  12/31/1969
Oregon Research Institute
mi
from
Eugene, OR
Child and Family Outcomes and Consumer Satisfaction for Online vs Staff-Delivered Parenting Intervention
Online vs Staff Delivery: Child & Family Outcomes, Value Analysis, Satisfaction
Status: Enrolling
Updated: 12/31/1969
Oregon Research Institute
mi
from
Eugene, OR
Click here to add this to my saved trials
Child and Family Outcomes and Consumer Satisfaction for Online vs Staff-Delivered Parenting Intervention
Online vs Staff Delivery: Child & Family Outcomes, Value Analysis, Satisfaction
Status: Enrolling
Updated:  12/31/1969
Parenting & Family Research Center, University of South Carolina
mi
from
Columbia, SC
Child and Family Outcomes and Consumer Satisfaction for Online vs Staff-Delivered Parenting Intervention
Online vs Staff Delivery: Child & Family Outcomes, Value Analysis, Satisfaction
Status: Enrolling
Updated: 12/31/1969
Parenting & Family Research Center, University of South Carolina
mi
from
Columbia, SC
Click here to add this to my saved trials
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
Status: Enrolling
Updated:  12/31/1969
University of Colorado Anschutz Medical Campus
mi
from
Aurora, CO
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
Status: Enrolling
Updated: 12/31/1969
University of Colorado Anschutz Medical Campus
mi
from
Aurora, CO
Click here to add this to my saved trials
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
Status: Enrolling
Updated:  12/31/1969
University of Colorado Boulder Intermountain Neuroimaging Consortium
mi
from
Boulder, CO
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
Status: Enrolling
Updated: 12/31/1969
University of Colorado Boulder Intermountain Neuroimaging Consortium
mi
from
Boulder, CO
Click here to add this to my saved trials
Impact of Exercise on Cognitive Impairment in End-Stage Renal Disease
Impact of Exercise on Cognitive Impairment in End-Stage Renal Disease
Status: Enrolling
Updated:  12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KA
Impact of Exercise on Cognitive Impairment in End-Stage Renal Disease
Impact of Exercise on Cognitive Impairment in End-Stage Renal Disease
Status: Enrolling
Updated: 12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Improving Medication Adherence in Older African Americans With Diabetes
Improving Medication Adherence in Older African Americans With Diabetes
Status: Enrolling
Updated:  12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
Improving Medication Adherence in Older African Americans With Diabetes
Improving Medication Adherence in Older African Americans With Diabetes
Status: Enrolling
Updated: 12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Technology to Enhance Treatment for Early Conduct Problems in Low Income Families
Technology to Enhance Treatment for Early Conduct Problems in Low Income Families
Status: Enrolling
Updated:  12/31/1969
UNC Department of Psychology Community Research Center and Clinic
mi
from
Chapel Hill, NC
Technology to Enhance Treatment for Early Conduct Problems in Low Income Families
Technology to Enhance Treatment for Early Conduct Problems in Low Income Families
Status: Enrolling
Updated: 12/31/1969
UNC Department of Psychology Community Research Center and Clinic
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Allopregnanolone for Mild Cognitive Impairment Due to Alzheimer's Disease or Mild AD
Allopregnanolone Regenerative Therapeutic for MCI/AD: Dose Finding Phase 1
Status: Enrolling
Updated:  12/31/1969
University of Southern California - Alzheimer Disease Research Center - Healthcare Consultation Center II
mi
from
Los Angeles, CA
Allopregnanolone for Mild Cognitive Impairment Due to Alzheimer's Disease or Mild AD
Allopregnanolone Regenerative Therapeutic for MCI/AD: Dose Finding Phase 1
Status: Enrolling
Updated: 12/31/1969
University of Southern California - Alzheimer Disease Research Center - Healthcare Consultation Center II
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Behavioral Interventions to Prevent or Delay Dementia
Comparative Effectiveness of Behavioral Interventions to Prevent or Delay Dementia (CEBIPODD)
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Behavioral Interventions to Prevent or Delay Dementia
Comparative Effectiveness of Behavioral Interventions to Prevent or Delay Dementia (CEBIPODD)
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials